{
    "clinical_study": {
        "@rank": "159781", 
        "arm_group": {
            "arm_group_label": "asthma patients", 
            "arm_group_type": "Experimental", 
            "description": "patients who show a positive response at the first dos of histamine challenge test will be enrolled"
        }, 
        "brief_summary": {
            "textblock": "Bronchial hyperresponsiveness consists in excessive response to bronchial stimuli.Bronchial\n      challenge test is used to confirm/exclude asthma (metacholine or histamine).Protection are\n      used to avoid passive exposure of the technicians performing the test, despite the absence\n      of evidence that they could develop a bronchoconstriction even if they suffer from BHR.The\n      purpose of the study is to determine if patients with a high level of bronchial\n      hyperreactivity and exposed passively to histamine during a bronchial challenge, are\n      developing a bronchoconstriction, when placed in the same conditions that the technicians\n      performing these tests."
        }, 
        "brief_title": "Bronchial Hyperreactivity During Histamine Passive Exposure", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Asthma", 
            "Bronchial Hyperresponsiveness"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Bronchial Hyperreactivity"
            ]
        }, 
        "detailed_description": {
            "textblock": "Bronchial hyperresponsiveness (BHR) consists in excessive response to bronchial\n      stimuli.Bronchial challenge test is used to confirm/exclude asthma.BHR is also present in\n      other diseases such as allergic rhinitis, Chronic Obstructive pulmonary disease,heart\n      failure..\n\n      Thes test is performed with metacholine or histamine with spirometric documented response to\n      incremental doses.Protection are used to avoid passive exposure of the technicians\n      performing the test, despite the absence of evidence that they could develop a\n      bronchoconstriction if they suffer from BHR.\n\n      The purpose of the study is to determine if patients, newly diagnosed with a high level of\n      bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge,\n      are reacting to histamine when placed in the same conditions that the technicians performing\n      these tests."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients with positive histamine challenge test (first dose)\n\n        Exclusion Criteria:\n\n          -  other active respiratory disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937494", 
            "org_study_id": "AK/13-03-34/4235"
        }, 
        "intervention": {
            "arm_group_label": "asthma patients", 
            "description": "passive exposure to histamine during a bronchial hyperresponsiveness challenge", 
            "intervention_name": "histamine-benzylic alcohol (magistral preparation)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Histamine", 
                "Histamine phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "asthma", 
            "bronchial hyperresponsiveness", 
            "histamine challenge test", 
            "spirometry"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "contact": {
                "email": "maria_gabrovska@stpierre-bru.be", 
                "last_name": "maria gabrovska, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1000"
                }, 
                "name": "service de pneumologie, CHU St Pierre"
            }, 
            "investigator": {
                "last_name": "maria Gabrovska, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests?", 
        "overall_contact": {
            "email": "maria_gabrovska@stpierre-bru.be", 
            "last_name": "Maria Gabrovska, MD", 
            "phone": "003225353368"
        }, 
        "overall_contact_backup": {
            "email": "marie_bruyneel@stpierre-bru.be", 
            "last_name": "Marie Bruyneel, MD", 
            "phone": "003225354219"
        }, 
        "overall_official": {
            "affiliation": "CHU ST Pierre", 
            "last_name": "Marie Bruyneel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "spirometric values in patients exposed passively to histamine during BHR challenge", 
            "safety_issue": "Yes", 
            "time_frame": "1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937494"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire Saint Pierre", 
            "investigator_full_name": "Marie Bruyneel", 
            "investigator_title": "CCA, pneumologie", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Centre Hospitalier Universitaire Saint Pierre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Saint Pierre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}